RLAY
Relay Therapeutics, Inc.
Nasdaq Biological Products, (No Diagnostic Substances) Large accelerated filer

Key Financials

Revenue
$15.4M
↑ 53.4%
Operating Income
$-302738000
↑ 18.7%
Net Income
$-276479000
↑ 18.1%
EPS (Diluted)
$-1.61
↑ 31.8%
Total Assets
$621.3M
↓ 28.7%
Cash & Equivalents
$84.0M
↓ 32.4%
Total Liabilities
$54.3M
↓ 42.0%
Shareholders' Equity
$567.1M
↓ 27.1%

Recent SEC Filings

Form Type Filed Date Link
4 6/10/2026 View on SEC
4 6/10/2026 View on SEC
4 6/10/2026 View on SEC
4 6/10/2026 View on SEC
4 6/10/2026 View on SEC
4 6/10/2026 View on SEC
4 6/10/2026 View on SEC
8-K 6/9/2026 View on SEC
8-K 5/21/2026 View on SEC
424B5 5/21/2026 View on SEC

Company Information

Field Value
Ticker RLAY
Company Name Relay Therapeutics, Inc.
CIK 1812364
Sector Biological Products, (No Diagnostic Substances)
Industry Large accelerated filer
Exchange Nasdaq
SIC Code 2836
SIC Description Biological Products, (No Diagnostic Substances)
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 617-370-8837